Similar Articles
New Treatment Strategies in the Treatment of Juvenile Idiopathic Arthritis
İbrahim GÖKÇE, Erkan DEMİRKAYA
DOI: 10.5606/tjr.2011.012
The Reported Adverse Effects Related to Biological Agents Used for the Treatment of Rheumatic Diseases in Turkey
Erkan KILIÇ, Gamze KILIÇ, Özgür AKGÜL, Gürkan AKGÖL, Salih ÖZGÖÇMEN
DOI: 10.5606/tjr.2013.3052
The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience
Dana HARB, Hiba MOUKADEM, Rabih NAYFE, Ali MEHDI, Abdel Fattah MASRI, Ziad SALEM, Ali TAHER, Imad UTHMAN
DOI: 10.5606/ArchRheumatol.2014.3855
A Rare Kind of Lymphoma in a Patient on Treatment With Two Different Biological Agents
Inesa ARSTIKYTE, Irena BUTRIMIENE, Agne PETRULIONIENE, Algirdas VENALIS
DOI: 10.5606/ArchRheumatol.2015.4383
Breast Involvement in Anti-Neutrophil Cytoplasmic Antibodies Positive Granulomatosis With Polyangiitis in a 64-Year-Old Female Patient
Monika RYBA, Andrzej KONIECZNY, Zbigniew HRUBY
DOI: 10.5606/ArchRheumatol.2017.6321
Immunoglobulin G4-Related Disease Presented as Recurrent Otitis Media and Mixed Hearing Loss Treated With Cyclophosphamide and Rituximab: A Case Report
Shao SAN, Chia-der LIN, Sheng-ta TSAI, Chao-chun LIN, Po-chang WU
DOI: 10.5606/ArchRheumatol.2019.7178
Cytomegalovirus Disease in a Patient With Granulomatosis With Polyangiitis Who Also Has Splenic Necrosis
Önay GERÇİK, Dilek SOLMAZ, Şebnem KARASU, Neşe EKİNCİ, Servet AKAR
DOI: 10.5606/ArchRheumatol.2019.7306
Rare Presentation of Severely Limited Granulomatosis With Polyangiitis Manifesting With Orbital Wall Destruction: Literature Review and Case Report
Erol HAVUZ, Seda GÜDÜL HAVUZ
DOI: 10.46497/ArchRheumatol.2020.7503
Predictive factors of mortality in granulomatosis with polyangiitis: A single-center study
Müge Aydın Tufan, Nihan Tekkarışmaz
DOI: 10.46497/ArchRheumatol.2021.8594
A retrospective review of antiphospholipid syndrome from a South Asian country
Muhammad Zain Mushtaq, Syed Ahsan Ali, Zaibunnisa Sattar, Saad Bin Zafar Mahmood, Tazein Amber, Mehmood Riaz
DOI: 10.46497/ArchRheumatol.2022.8979
Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
Tsvetelina Yoneva, Yana Zdravkova, Georgi Kotov, Ekaterina Ivanova Todorova, Georgi Vasilev, Rasho Rashkov, Ivan Sheytanov
DOI: 10.46497/ArchRheumatol.2023.9556
Performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for antineutrophil cytoplasmic antibody-associated vasculitis in previously diagnosed adult patients from Türkiye
Sedat Yilmaz, Hamit Kucuk, Merve Sungur Ozgunen, Riza Can Kardas, Duygu Tecer, Ibrahim Vasi, Muhammet Cinar, Mehmet Akif Ozturk
DOI: 10.46497/ArchRheumatol.2024.10268
Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis
Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria
DOI: 10.46497/ArchRheumatol.2024.10199